US2009286288A1PendingUtilityA1
ALPHA-1, 4-GALACTOSYLTRANSFERASE (CgtD) FROM CAMPYLOBACTER JEJUNI
Est. expiryMay 2, 2026(expired)· nominal 20-yr term from priority
C12N 9/107C12N 9/1051C12P 19/18C12Y 204/01038
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
α-1,4-galactosyltransferase (CgtD) polypeptides, nucleic acids that encode the polypeptides, including a polypeptide from Campylobacter jejuni strain LIO87 have been isolated and characterized A method of producing a galactosylated saccharide comprising contacting an acceptor saccharide containing a terminal galactose, a donor substrate comprising a galactose moiety and one of the CgtD polypeptides is described.
Claims
exact text as granted — not AI-modified1 . A method of producing a galactosylated product saccharide, the method comprising the step of:
a) contacting an acceptor substrate with a donor substrate comprising a galactose moiety and an isolated or recombinant α-1,4-galactosyltransferase polypeptide with at least 80% identity to SEQ ID NO:2; and b) allowing transfer of a galactose moiety to the acceptor saccharide to occur, thereby producing the galactosylated product saccharide.
2 . The method of claim 1 , wherein the α-1,4-galactosyltransferase polypeptide comprises an amino acid sequence with at least 90% identity to SEQ ID NO:2.
3 . The method of claim 1 , wherein the α-1,4-galactosyltransferase polypeptide comprises an amino acid sequence with at least 95% identity to SEQ ID NO:2.
4 . The method of claim 1 , wherein the α-1,4-galactosyltransferase polypeptide comprises an amino acid sequence of SEQ ID NO:2.
5 . The method of claim 1 , wherein the method is performed at a commercial scale of production.
6 . A reaction mixture comprising an isolated or recombinant α-1,4-galactosyltransferase polypeptide, wherein the α-1,4-galactosyltransferase polypeptide comprises an amino acid sequence with at least 80% identity to SEQ ID NO:2, and wherein the α-1,4-galactosyltransferase polypeptide transfers a galactose moiety from a donor substrate to an acceptor substrate.
7 . The reaction mixture of claim 6 , wherein the α-1,4-galactosyltransferase polypeptide comprises an amino acid sequence with at least 90% identity to SEQ ID NO:2.
8 . The reaction mixture of claim 6 , wherein the α-1,4-galactosyltransferase polypeptide comprises an amino acid sequence with at least 95% identity to SEQ ID NO:2.
9 . The reaction mixture of claim 6 , wherein the α-1,4-galactosyltransferase polypeptide comprises an amino acid sequence of SEQ ID NO:2.
10 . An isolated nucleic acid the encodes an α-1,4-galactosyltransferase polypeptide of claim 6 , wherein the isolated nucleic acid comprises a nucleic acid sequence with at least 80% identity to SEQ ID NO: 1.
11 . The isolated nucleic acid of claim 10 , wherein the isolated nucleic acid comprises a nucleic acid sequence with at least 90% identity to SEQ ID NO: 1.
12 . The isolated nucleic acid of claim 10 , wherein the isolated nucleic acid comprises a nucleic acid sequence with at least 95% identity to SEQ ID NO: 1.
13 . The isolated nucleic acid of claim 10 , wherein the isolated nucleic acid comprises a nucleic acid sequence of SEQ ID NO: 1.
14 . An expression vector comprising a nucleic acid sequence of claim 10 .
15 . A host cell comprising the expression vector of claim 14 .Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.